title: Trovafloxacin-induced acute hepatitis.
authors.affiliation: Servicio de Farmacología Clínica, Facultad de Medicina, Campus Universitario de Teatinos s/n, 29071 Málaga, Spain. lucena@uma.es
authors.forename: M I
authors.initials: MI
authors.lastname: Lucena
authors.forename: R J
authors.initials: RJ
authors.lastname: Andrade
authors.forename: L
authors.initials: L
authors.lastname: Rodrigo
authors.forename: J
authors.initials: J
authors.lastname: Salmerón
authors.forename: A
authors.initials: A
authors.lastname: Alvarez
authors.forename: M J
authors.initials: MJ
authors.lastname: Lopez-Garrido
authors.forename: R
authors.initials: R
authors.lastname: Camargo
authors.forename: R
authors.initials: R
authors.lastname: Alcantára
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001707:Biopsy, Needle; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D024841:Fluoroquinolones; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009287:Naphthyridines / Q000008:administration & dosage / Q000009:adverse effects*; D011018:Pneumonia, Pneumococcal / Q000175:diagnosis / Q000188:drug therapy*; D011379:Prognosis; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; C080163:trovafloxacin